ArticleFrontiers in pharmacology2021

Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.

Claudia Tregnago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.